Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Slevin

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
British Journal of Cancer|March 1, 1992
A study to investigate the incidence of early satiety in patients with advanced cancerP J Armes, H J Plant, A Allbright, et al.
British Journal of Clinical Pharmacology|March 16, 2000
The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphineR Stuart-Harris, S P Joel, P McDonald, et al.
Haematology and Blood Transfusion|January 1, 1983
The clinical pharmacology of cytosine arabinosideM L Slevin, E M Piall, G W Aherne, et al.
Medical and Pediatric Oncology|January 1, 1982
The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapyM L Slevin, E M Piall, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusionM L Slevin, E M Piall, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphomaA Rohatiner, M L Slevin, H S Dhaliwal, et al.
Journal of Immunological Methods|August 30, 1992
Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditionsP W Thavasu, S Longhurst, S P Joel, et al.
Human Nutrition. Applied Nutrition|August 1, 1987
Oral protein and energy supplements in cancer patientsS A Parkinson, J Lewis, R Morris, et al.
British Journal of Cancer|September 1, 1985
The effect of food and concurrent chemotherapy on the bioavailability of oral etoposideV J Harvey, M L Slevin, S P Joel, et al.
Cancer Treatment Reports|June 1, 1985
High-dose etoposide in the treatment of relapsed primary brain tumorsG P Finn, T Bozek, R L Souhami, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|March 1, 1992
A study to investigate the incidence of early satiety in patients with advanced cancerP J Armes, H J Plant, A Allbright, et al.
British Journal of Clinical Pharmacology|March 16, 2000
The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphineR Stuart-Harris, S P Joel, P McDonald, et al.
Haematology and Blood Transfusion|January 1, 1983
The clinical pharmacology of cytosine arabinosideM L Slevin, E M Piall, G W Aherne, et al.
Medical and Pediatric Oncology|January 1, 1982
The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapyM L Slevin, E M Piall, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusionM L Slevin, E M Piall, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphomaA Rohatiner, M L Slevin, H S Dhaliwal, et al.
Journal of Immunological Methods|August 30, 1992
Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditionsP W Thavasu, S Longhurst, S P Joel, et al.
Human Nutrition. Applied Nutrition|August 1, 1987
Oral protein and energy supplements in cancer patientsS A Parkinson, J Lewis, R Morris, et al.
British Journal of Cancer|September 1, 1985
The effect of food and concurrent chemotherapy on the bioavailability of oral etoposideV J Harvey, M L Slevin, S P Joel, et al.
Cancer Treatment Reports|June 1, 1985
High-dose etoposide in the treatment of relapsed primary brain tumorsG P Finn, T Bozek, R L Souhami, et al.
Pageof 14